Nicola advises companies on all aspects of corporate law including the delivery of funding rounds and strategies for growth and realisation of value. With a strong technology focus, she has acted for several companies from early stage through to major institutional funding rounds, strategic acquisitions and exit via sale or IPO. Her clients include organisations in the life sciences, digital and clean tech sectors, many of which have an international dynamic to their business. She also has an impressive track record in advising on technology transfer from educational institutions.
Through her expertise in clean tech and renewable energy, Nicola has been approached by several community groups recognised as early adopters of social enterprise business models. This means she is familiar with various social enterprise entities as well as the regulations surrounding governance and raising finance. She has advised many high profile groups across the UK and is a non-executive director of Westmill Solar Co-operative which raised funding through a public share offer to secure ownership of what is now the largest community owned solar park in Europe.
Nicola joined Penningtons Manches in 2016 from a leading regional law firm where she had been a partner for eight years. She is recognised by both Chambers UK and The Legal 500, winning praise for coming up with ‘simple but effective solutions to complex legal issues’ and for being ‘absolutely charming and very competent’. She has also been described by clients in the directories as ‘the best person in southern England on green technology who is absolutely passionate about her job’ and as having ‘a palpable determination to drive change’.
Sue Staunton is an Audit and Assurance Partner at James Cowper Kreston. She also has a particular interest in working with technology businesses and their owners and, as such, heads our technology team.
Sue works with clients on the development and implementation of their corporate strategies. She also has a great deal of experience in working with businesses in financial crisis to establish strategies to assist them to move forward successfully.
Riham Satti, CEO of MeVitae and TEDx speaker is amongst the top 50 disruptive game changers in Thames Valley, top 100 influential UK tech business leaders and according to Forbes a ‘female founder taking the UK by storm’. Riham gained the degrees in clinical neuroscientist from Oxford, and Biomedical Engineering at Imperial College London. As well as her involvement in the tech ecosystem and working with innovative start-up companies, Riham’s main interests lie in leveraging technology to diversify the STEM workforce, supported by the likes of Microsoft, European Space Agency and Oxford University. She is also involved in several initiatives in promoting female founders and women in STEM.
Carolyn has held commercial roles in several sectors including Big Pharma, Biotech, Finance and the University sector. She is currently Chief Business Officer of OxStem, one of the 16 companies she helped spin-out of Oxford University in a previous role as Deputy Head of Technology Transfer at Oxford. She has been a member of the investment committee of a £13M fund and has held board positions in 5 companies. Previously Carolyn held senior business development roles in Pharma and Biotech companies working on in/out licensing, acquisitions and strategic alliances. Her earlier career included working as a biotech analyst and then in Corporate Finance at Ernst & Young where she assisted companies with fundraising, acquisitions and company sales. Carolyn has a PhD in Immunology, an honours degree in Pharmacology and an MBA. Carolyn is passionate about supporting women in the workplace as she believes a fully functioning workplace requires women at all levels to be able to realise their full potential.
Danuta is co-founder and CEO of Nucleome Therapeutics, a pre-incorporation genomics spinout from the University of Oxford that uses the 3D structure of the genome to link disease associated genetic variants with affected genes for novel drug targets discovery from the largely unexplored non-coding part of the genome.
Danuta has extensive expertise in decrypting how genes are regulated, acquired over the last 11 years. She obtained her BSc in Biotechnology, PhD in Systems Biology and has continued her scientific research at the MRC Weatherall Institute of Molecular Medicine at Oxford University since 2011.
Danuta was named as one of the Movers and Shakers in BioBusiness in recognition for supporting innovation from concept to market. She co-founded Innovation Forum Oxford that accelerates innovative technology development by building bridges between academics, industry, the NHS and policy makers whilst providing entrepreneurial training to hundreds of scientists in health and life sciences.
Nicky co-founded Best Foot Forward, a sustainability consultancy that pioneered development of carbon and ecological foot-printing. She is now Strategy Advisor at Anthesis Consulting Group and helps organisations respond to, and benefit from, the threats and opportunities of sustainability.
Philippa is a Licensing and Ventures Manager at Oxford University Innovation (OUI) in the Digital Health and Medical Devices team. Since 2016, she has worked with researchers across the University of Oxford to help them create impact with their ideas. Whilst a large number of her projects are in the digital health space, Philippa has facilitated spinout companies from the Humanities and Social Sciences Divisions. She is delighted to be increasingly working with projects focussed on mental health issues, with an emphasis on support the Oxford Health NHS Foundation Trust.
Philippa also has a passion for social enterprises, companies that put purpose before profit, and is part of the team offering support to create these entities from the University. Philippa was part of the team that set up OxReach, the crowdfunding platform for social good projects from the University of Oxford. She has supported four successful campaigns which have all benefitted substantially from the public support that they received and are now creating local and international impact.